Vontobel Holding’s OptimizeRx OPRX Stock Holding History

Vontobel Holding’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-40,025	Closed	-$1.52M	–	1093
2022 Q1	$1.52M	Buy	+40,025	New	+$1.77M	0.01%	496
2021 Q4	–	Sell	-5,419	Closed	-$464K	–	1171
2021 Q3	$464K	Sell	5,419 -16,022	-75%	-$1.01M	﹤0.01%	819
2021 Q2	$1.33M	Buy	21,441 +8,366	+64%	+$426K	0.01%	526
2021 Q1	$637K	Buy	+13,075	New	+$631K	﹤0.01%	617

Other funds holding OPRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $549M AUM 179.59% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return

Vontobel Holding's OPRX Position: Q2 2022 in Review

Vontobel Holding sold out of OptimizeRx (OPRX) in Q2 2022, closing a stake of 40,025 shares — an estimated $1.52M sold.

Vontobel Holding first reported a position in OPRX in Q1 2021 and held it in 4 quarters. The position peaked at $1.52M in Q1 2022. 146 funds tracked by Wall St. Rank hold OPRX as of Q2 2022.

Vontobel Holding reported no remaining OptimizeRx position as of Q2 2022 after selling out during the quarter.
Vontobel Holding sold 40,025 OptimizeRx shares in Q2 2022, an estimated $1.52M.
Vontobel Holding first reported a position in OptimizeRx in Q1 2021 and held it in 4 quarters.
Vontobel Holding's OptimizeRx position peaked at $1.52M in Q1 2022.
146 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2022.

Based on Vontobel Holding's 13F filing for Q2 2022, filed 27 Jul 2022.